These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39661366)

  • 1. Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study.
    Gentile I; Viceconte G; Cuccurullo F; Pietroluongo D; D'Agostino A; Silvitelli M; Mercinelli S; Scotto R; Grimaldi F; Palmieri S; Gravetti A; Trastulli F; Moccia M; Buonomo AR
    Ann Med; 2025 Dec; 57(1):2439541. PubMed ID: 39661366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Potential Drug Interactions With Direct-Acting Antivirals for COVID-19 Among Hospitalized Patients.
    Mozaffari E; Chandak A; Ustianowski A; Rivera CG; Ahuja N; Jiang H; Berry M; Okulicz JF; Amin AN
    Clin Ther; 2024 Oct; 46(10):778-784. PubMed ID: 39244489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort study.
    Pinargote-Celorio H; Moreno-Pérez Ó; González-De-La-Aleja P; Llenas-García J; Martínez Pérez-Crespo PM; Rodríguez-Díaz JC; Martínez-López B; Merchante Gutiérrez N; Ramos-Rincón JM; Merino E
    J Antimicrob Chemother; 2024 Dec; 79(12):3248-3253. PubMed ID: 39374379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in China.
    Han B; Du C; Deng M; Tang R; Dong J; Song X; Qiao Y; Ni Z; Yang W; Yang J; Xiang T; Huang Y; Zhong Y; Zhang Z; Yang L; Yang J; Wang J; Zheng L; Ma L; Shou Z; Cao R; Ma J; He G; Yuan J; Pang C; Xu J; Huang J; Yuan X; Wu Y; Xiong Y; Zhang X; Liu H; Gao B; Chen H; Ma T; Dang S; Zhang Q; Yuan R; Wei Y; Xu T; Deng Z; Gong Y; Gao J; Jiang R
    J Infect; 2024 Dec; 89(6):106339. PubMed ID: 39521253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.
    Sridhar S; Joaquin A; Bonaparte MI; Bueso A; Chabanon AL; Chen A; Chicz RM; Diemert D; Essink BJ; Fu B; Grunenberg NA; Janosczyk H; Keefer MC; Rivera M DM; Meng Y; Michael NL; Munsiff SS; Ogbuagu O; Raabe VN; Severance R; Rivas E; Romanyak N; Rouphael NG; Schuerman L; Sher LD; Walsh SR; White J; von Barbier D; de Bruyn G; Canter R; Grillet MH; Keshtkar-Jahromi M; Koutsoukos M; Lopez D; Masotti R; Mendoza S; Moreau C; Ceregido MA; Ramirez S; Said A; Tavares-Da-Silva F; Shi J; Tong T; Treanor J; Diazgranados CA; Savarino S
    Lancet Infect Dis; 2022 May; 22(5):636-648. PubMed ID: 35090638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of early versus late remdesivir treatment in hospitalized mild to moderate COVID-19 patients in the Omicron era: A retrospective study.
    Ryu BH; Lee JY; Lee SH
    Medicine (Baltimore); 2024 Jul; 103(29):e39035. PubMed ID: 39029053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir-Associated Survival Outcomes Among Immunocompromised Patients Hospitalized for COVID-19: Real-world Evidence From the Omicron-Dominant Era.
    Mozaffari E; Chandak A; Gottlieb RL; Chima-Melton C; Berry M; Amin AN; Sax PE; Kalil AC
    Clin Infect Dis; 2024 Dec; 79(Supplement_4):S149-S159. PubMed ID: 39405443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of early administration of remdesivir in hemodialysis patients with COVID-19: A case report and literature review.
    Oshiro N; Kinjo T; Aharen D; Kudo Y; Katsuren E; Omine K; Nakamura T; Zamami R; Ishida A; Miyagi K; Nakamatsu M; Yamamoto K; Kusunose K; Fujita J; Ohya Y; Kohagura K
    Medicine (Baltimore); 2024 Nov; 103(48):e40650. PubMed ID: 39612460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early combination therapy of COVID-19 in high-risk patients.
    Orth HM; Flasshove C; Berger M; Hattenhauer T; Biederbick KD; Mispelbaum R; Klein U; Stemler J; Fisahn M; Doleschall AD; Baermann BN; Koenigshausen E; Tselikmann O; Killer A; de Angelis C; Gliga S; Stegbauer J; Spuck N; Silling G; Rockstroh JK; Strassburg CP; Brossart P; Panse JP; Jensen BO; Luedde T; Boesecke C; Heine A; Cornely OA; Monin MB
    Infection; 2024 Jun; 52(3):877-889. PubMed ID: 38017344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.
    Seethamraju H; Yang OO; Loftus R; Ogbuagu O; Sammartino D; Mansour A; Sacha JB; Ojha S; Hansen SG; Arman AC; Lalezari JP
    Clin Ther; 2024 Nov; 46(11):891-899. PubMed ID: 39353749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for women with postpartum iron deficiency anaemia.
    Jensen MCH; Holm C; Jørgensen KJ; Schroll JB
    Cochrane Database Syst Rev; 2024 Dec; 12(12):CD010861. PubMed ID: 39670550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient remdesivir treatment program for hospitalized patients with coronavirus disease-2019: Patient perceptions, process and economic impact.
    Chesdachai S; Rivera CG; Rosedahl JK; Philpot LM; Dholakia R; Borah BJ; Draper EW; Arndt R; Ganesh R; Larsen JJ; Destro Borgen MJ; Razonable RR
    Healthc (Amst); 2024 Dec; 12(4):100750. PubMed ID: 39142233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of the antiviral medications azvudine and nirmatrelvir-ritonavir in treating COVID-19 in patients with hematological malignancies.
    Zeng Z; Li F; Zhong M; Zhu L; Chen W; Wang X
    Clinics (Sao Paulo); 2024; 79():100406. PubMed ID: 39059144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the effects of remdesivir on corrected QT interval in patients with severe COVID-19 disease: a historical cohort study.
    Saffar H; Nabati M; Saffar N; Yazdani J
    BMC Cardiovasc Disord; 2024 Dec; 24(1):700. PubMed ID: 39633288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicomponent psychosocial intervention to reduce substance use by adolescents involved in the criminal justice system: the RISKIT-CJS RCT.
    Coulton S; Nizalova O; Pellatt-Higgins T; Stevens A; Hendrie N; Marchand C; Vass R; Deluca P; Drummond C; Ferguson J; Waller G; Newbury-Birch D
    Public Health Res (Southampt); 2023 Mar; 11(3):1-77. PubMed ID: 37254608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.